Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,102.07
(
-0.50%
)
US TECH 100
26,070.80
(
-0.51%
)
Dow Jones
49,248.28
(
-0.49%
)
Brent Oil
100.34
(
3.74%
)
Bitcoin
77,917.33
(
-0.41%
)
News Focus
News Focus
Post# of 822579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sentiment_stocks

Send PM Follow Ignore
Followers 238
Posts 15504
Boards Moderated 1
Alias Born 03/29/2014

sentiment_stocks

Member Level

Re: iclight post# 796899

Saturday, 11/08/2025 6:03:29 PM

Saturday, November 08, 2025 6:03:29 PM

Post# of 822579
This trial:
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

https://clinicaltrials.gov/study/NCT04201873?lat=34.0648474&lng=-118.4471591&locStr=UCLA%20Medical%20Center,%20Medical%20Plaza,%20Los%20Angeles,%20CA&distance=50&cond=ATL%20dc&rank=1

And please note, LL’s comment was made in May 2024.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News